论文部分内容阅读
目的观察β-受体阻滞剂美托洛尔治疗慢性充血性心力衰竭(CHF)的临床疗效。方法将68例CHF患者随机分为美托洛尔组和常规治疗组,美托洛尔组在常规抗心衰治疗的基础上给予美托洛尔;常规治疗组采用安慰剂加常规抗心衰治疗。结果治疗组心率减慢,血压下降,心脏射血分数增加,心功能改善,均优于对照组。结论CHF患者在常规抗心衰治疗基础上加用美托洛尔能改善心功能,改善预后。
Objective To observe the clinical efficacy of β-blocker metoprolol in the treatment of chronic congestive heart failure (CHF). Methods Sixty-eight patients with CHF were randomly divided into metoprolol group and metoprolol group. Metoprolol group was given metoprolol on the basis of routine anti-heart failure treatment. Conventional treatment group was given placebo plus conventional anti-heart failure treatment. Results The treatment group, heart rate slowed down, blood pressure, increased cardiac ejection fraction, cardiac function improved, were better than the control group. Conclusions Metoprolol can improve cardiac function and improve prognosis in patients with CHF based on routine anti-heart failure treatment.